Knowledge and Practice Patterns Among Pulmonologists for Molecular Biomarker Testing in Advanced Non-small Cell Lung Cancer.

ABSTRACT:

Background

Targeted therapies for advanced non-small cell lung cancer (NSCLC) with oncogenic drivers have caused a paradigm shift in care. Biomarker testing is needed to assess eligibility for these therapies. Pulmonologists often perform bronchoscopy, providing tissue for both pathologic diagnosis and biomarker analysis. We performed this survey to define the existing knowledge and practices regarding the pulmonologists' role in biomarker testing for advanced NSCLC.

Research question

What is the current knowledge and practice of pulmonologists regarding biomarker testing and targeted therapies in advanced NSCLC?

Study design and methods

This cross-sectional study was performed using an electronic survey of a random sample of 7,238 pulmonologists. Questions focused on

SUBMITTER: Fox AH 

PROVIDER: S-EPMC8727850 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature